Source - LSE Regulatory
RNS Number : 7946W
Indivior PLC
28 April 2021
 

Statement re: State Announcements

 

In response to various States Attorney General's recent announcements regarding SUBOXONE® (buprenorphine and naloxone ) Film settlements, Indivior made the following statement:

 

·    The various state settlement agreements being announced this week are administrative in nature, and simply formalize the individual state settlements which were previously agreed to in principle as part of the July 2020 criminal and civil resolution between Indivior and the states (and the federal government). As such, there is no new financial or legal obligation that has arisen. The Company was pleased to put those issues behind it in 2020 and remains focused on realizing its patient-focused Vision and fulfilling its compliance commitments.

 

The Company will have no further comment on this matter.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFDLLLFZLLBBL
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.